MeiraGTx Holdings (MGTX) Change in Accured Expenses (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Change in Accured Expenses of $22.0 million for Q4 2025, down 5.96% on a YoY basis from $23.4 million in Q4 2024, and down 45.24% quarter-over-quarter from $40.2 million in Q3 2025.

MeiraGTx Holdings (MGTX) Change in Accured Expenses (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Change in Accured Expenses for 9 years, with the latest figure at $22.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 5.96% year-over-year to $22.0 million; the trailing twelve-month figure through Dec 2025 stood at $49.5 million (up 154728.12% YoY), and the FY2025 full-year result was $49.5 million, up 154728.12% from the prior year.
  • Change in Accured Expenses for Q4 2025 stood at $22.0 million, down from $40.2 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $40.2 million in Q3 2025, with the low at -$25.0 million in Q2 2024.
  • Historically, Change in Accured Expenses has averaged $3.0 million across 5 years, with a median of $2.0 million in 2022.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 15862.5% — and 2025, when it soared 2444.49%.
  • MeiraGTx Holdings' Change in Accured Expenses stood at $8.1 million in 2021, then tumbled by 70.36% to $2.4 million in 2022, then jumped by 420.6% to $12.6 million in 2023, then soared by 86.13% to $23.4 million in 2024, then decreased by 5.96% to $22.0 million in 2025.
  • The last three Change in Accured Expenses figures came in at $22.0 million (Q4 2025), $40.2 million (Q3 2025), and -$9.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn 21.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 21.99 Mn
Dec 31, 2025 21.99 Mn
Sep 30, 2025 40.15 Mn
Sep 30, 2025 40.15 Mn
Jun 30, 2025 -9.01 Mn
Jun 30, 2025 -9.01 Mn
Mar 31, 2025 -3.59 Mn
Mar 31, 2025 -3.59 Mn
Dec 31, 2024 23.38 Mn
Dec 31, 2024 23.38 Mn
Sep 30, 2024 1.58 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 -24.97 Mn
Jun 30, 2024 -24.97 Mn
Mar 31, 2024 37,000.00
Mar 31, 2024 37,000.00
Dec 31, 2023 12.56 Mn
Dec 31, 2023 12.56 Mn
Sep 30, 2023 3.32 Mn
Sep 30, 2023 3.32 Mn